Say hello, explore a clinical partnership, or ask about investment opportunities — we’d love to hear from you.
Please email contact@hemasense.com.
Your message has been received. We’ll be in touch shortly.
The latest
HemaSense closed an oversubscribed $630,000 pre-seed financing round backed by 19 individual angel investors. The round, combined with non-d...
Read more →
Nathan Friedman, CEO, shared the results of the first preclinical animal study of the HemaSense Device on the Innovation stage at TCT 2025....
Read more →HemaSense received $250,000 in funding through PEI’s WearTech Applied Research Center to support continued development of its wearable techn...
Read more →
Nathan Friedman, CEO and Co-founder of HemaSense, shared a practical framework for early-stage medtech development at the MedTech Summit. Th...
Read more →
HemaSense was awarded second place at the 2025 Venture Madness pitch competition, earning a $7,500 prize. The recognition highlighted HemaSe...
Read more →